Brief: Resaas And Questcap Enter Into Commercial Agreement To Sell FDA Eua Covid-19 Igg/Igm Antibody Tests
26/08/2020 13:42
Aug 26 (Reuters) - QuestCap Inc QSC.CD :
* PRESS RELEASE - RESAAS AND QUESTCAP ENTER INTO COMMERCIAL
AGREEMENT TO SELL FDA EUA COVID-19 IGG/IGM ANTIBODY TESTS
* QUESTCAP - CO, ITS UNIT , WILL WORK WITH RESAAS
EXCLUSIVELY TO
CO'S COVID-19 IGG/IGM ANTIBODY TEST KITS WITHIN NORTH AMERICA TO
REAL ESTATE SECTOR
Source text for Eikon: ID:nGNX7l29wG
Further company coverage: QSC.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resaas Services
See all newsBrief: Resaas Announces Closing Of Non-Brokered Private Placement
Brief: Resaas Integrates Ai Into Commercial Data Exchange Platform, Streamlining Data Integration For Brokerages And Landlords
Brief: RESAAS Appoints Industry Titan James Huang as Managing Director of Commercial Real Estate
Brief: Resaas Enters Into Partnership With Rocket Mortgage Canada
Brief: Resaas Expands Relationship With Re/Max® Across United States